retatrutide mg retatrutide-and-cagrilintide-15mg-5mg Retatrutide 40 mg — research

Monthly status conferences will begin January 14, and a decision on preemption may come by year-end

The EMAs review, launched in December 2024, found that the risk of developing NAION more than doubled in patients taking semaglutide compared to those on other diabetes medications, with an estimated frequency of up to 1 in 10,000

Food and Drug Administration Revised 05/2025 Medication Guide Package/Label Display Panel 5 mcg 5 mcg per dose NDC 0310-6512-01 Byetta exenatide injection 250 mcg/mL, 1.2 mL Dispense the enclosed Medication Guide to each patient For Single Patient Use Only Each prefilled pen will deliver 60 subcutaneous doses, 5 mcg per dose Rx only SUBCUTANEOUS USE ONLY REFRIGERATE DO NOT FREEZE DO NOT TRANSFER THIS MEDICATION TO A SYRINGE Pen needles not included Ask your healthcare provider which pen needle length and gauge is best for you Use 29 (thin), 30, or 31 (thinner) gauge disposable pen needles AstraZeneca Package/Label Display Panel 10 mcg 10 mcg per dose NDC 0310-6524-01 Byetta exenatide injection 250 mcg/mL, 2.4 mL Dispense the enclosed Medication Guide to each patient For Single Patient Use Only Each prefilled pen will deliver 60 subcutaneous doses, 10 mcg per dose Rx only SUBCUTANEOUS USE ONLY REFRIGERATE DO NOT FREEZE DO NOT TRANSFER THIS MEDICATION TO A SYRINGE Pen needles not included Ask your healthcare provider which pen needle length and gauge is best for you Use 29 (thin), 30, or 31 (thinner) gauge disposable pen needles AstraZeneca Labeler - AstraZeneca Pharmaceuticals LP (054743190) Frequently asked questions Which GLP-1 drug is best for weight loss

Support your body's ability to mobilize and clear stored toxins during fat loss with cruciferous vegetables, sulfur-rich amino acids, hydration, and antioxidant nutrients